Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference41 articles.
1. Targeting CD47 as a Novel Immunotherapy for Breast Cancer;Chen;Front. Oncol.,2022
2. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells;Majeti;Cell,2009
3. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors;Willingham;Proc. Natl. Acad. Sci. USA,2012
4. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma;Chao;Cell,2010
5. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system;Okazawa;J. Immunol.,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment;Bioactive Materials;2024-12
2. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
3. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy;Molecular Cancer;2024-08-26
4. CD24 flags anastasis in melanoma cells;Apoptosis;2024-08-13
5. Red ginseng ameliorates lipotoxicity-induced renal fibrosis in hyperuricemia mice;Journal of Ethnopharmacology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3